LOCUS       sequence-98725-e        1118 bp    DNA     linear   UNA 15-DEC-2025
DEFINITION  Expressed murine IFITM3-C71,105A with an N-terminal HA tag in 
            mammalian cells.
ACCESSION   .
VERSION     .
KEYWORDS    .
SOURCE      natural DNA sequence
  ORGANISM  unspecified
REFERENCE   1  (bases 1 to 1118)
  AUTHORS   Yount JS, Moltedo B, Yang YY, Charron G, Moran TM, Lopez CB, Hang HC
  TITLE     Palmitoylome profiling reveals S-palmitoylation-dependent antiviral 
            activity of IFITM3.
  JOURNAL   Nat Chem Biol. 2010 Aug;6(8):610-4. doi: 10.1038/nchembio.405. Epub 
            2010 Jul 4.
  PUBMED    20601941
REFERENCE   2  (bases 1 to 1118)
  AUTHORS   .
  TITLE     Direct Submission
  JOURNAL   Exported Dec 15, 2025 from SnapGene Server 8.0.1
            https://www.snapgene.com
COMMENT     SGRef: number: 1; type: "Journal Article"; doi: 
            "10.1038/nchembio.405"; journalName: "Nat Chem Biol"; date: 
            "2010-08"; volume: "6"; issue: "8"; pages: "610-4"
COMMENT     Sequence Label: pCMV-HA-mIFITM3-C71,105A
FEATURES             Location/Qualifiers
     source          1..1118
                     /mol_type="genomic DNA"
                     /organism="unspecified"
     CDS             complement(487..513)
                     /codon_start=1
                     /product="HA (human influenza hemagglutinin) epitope tag"
                     /label=HA
                     /translation="YPYDVPDYA"
     intron          577..673
                     /label=SV40 intron
                     /note="modified SV40 intron with splice donor and acceptor 
                     sites"
     primer_bind     complement(790..814)
                     /label=LNCX
                     /note="Human CMV promoter, forward primer"
     promoter        complement(811..1014)
                     /label=CMV promoter
                     /note="human cytomegalovirus (CMV) immediate early 
                     promoter"
     primer_bind     complement(840..860)
                     /label=CMV-F
                     /note="Human CMV immediate early promoter, forward primer"
ORIGIN
        1 gtctggatcc ccgcggccgc ggtacctcga gagatctcgg tcgacttaag tgtgaaggtt
       61 ttgagcgtta agaacaatga tgatgacact aacaatggtg ataacaacca tcaggatgct
      121 gaggaccaag gtgctgatgt tcagtgcctt agcagtggag gcgtaggcct gggctccagt
      181 cacatcaccc accatcttcc gatccctaga cttcacggag taggcatagg ctatgaagcc
      241 caggcatgcg aagttcatga agagtgtatt gaacagggac cagaccacat ggtcaggcac
      301 cgacacctct ctgggcatgt tgatcacagt agttctgaca gaagccgatc cgtgcggtgc
      361 ccccatctca gccacctcat attcttcctt gattctttcg tagtttgggg gctgtcctcc
      421 actggcagcg gtgatgaagg cttgagaagt gtggttcatg ggaattcggg cctccatggc
      481 cataagagcg taatctggaa catcgtatgg gtacatggtg ggcccgcggg tacaattccg
      541 cagcttttag agcagaagta acacttccgt acaggcctag aagtaaaggc aacatccact
      601 gaggagcagt tctttgattt gcaccaccac cggatccggg acctgaaata aaagacaaaa
      661 agactaaact taccagttaa ctttctggtt tttcagttcc tctagtaccg gatcctctag
      721 agtccggagg ctggatcggt cccggtgtct tctatggagg tcaaaacagc gtggatggcg
      781 tctccaggcg atctgacggt tcactaaacg agctctgctt atatagacct cccaccgtac
      841 acgcctaccg cccatttgcg tcaatggggc ggagttgtta cgacattttg gaaagtcccg
      901 ttgattttgg tgccaaaaca aactcccatt gacgtcaatg gggtggagac ttggaaatcc
      961 ccgtgagtca aaccgctatc cacgcccatt gatgtactgc caaaaccgca tcaccatggt
     1021 aatagcgatg actaatacgt agatgtactg ccaagtagga aagtcccata aggtcatgta
     1081 ctgggcataa tgccaggcgg gccatttacc gtcattga
//
